Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Binding of ATGs to Endothelial Cells In Vivo.

Beiras-Fernandez A, Hernandez-Sierra A, Schulz U, Richter M, Thein E, Moritz A, Werner I.

Ann Transplant. 2016 May 17;21:311-6.

2.

Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury.

Beiras-Fernandez A, Chappell D, Hammer C, Beiras A, Reichart B, Thein E.

Transpl Immunol. 2009 Mar;20(4):224-8. doi: 10.1016/j.trim.2008.11.004. Epub 2008 Nov 28.

PMID:
19041395
3.

Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model.

Beiras-Fernandez A, Chappell D, Hammer C, Thein E.

Transpl Immunol. 2006 Apr;15(4):273-9. Epub 2006 Mar 24.

PMID:
16635749
4.

Antithymocyte globulins bind to human umbilical vein endothelial cells.

Beiras-Fernandez A, Walther S, Csapo C, Muenzing S, Hammer C, Reichart B, Thein E.

Transplant Proc. 2009 Jul-Aug;41(6):2286-8. doi: 10.1016/j.transproceed.2009.06.082.

PMID:
19715899
5.

Dose/time-dependent modulation of the endothelial function through induction agents: non-depleting versus depleting agents.

Werner I, Bogert NV, Stock UA, Moritz A, Beiras-Fernandez A.

Transplant Proc. 2014 Nov;46(9):2953-6. doi: 10.1016/j.transproceed.2014.06.055.

PMID:
25420800
6.

A review on comparing two commonly used rabbit anti-thymocyte globulins as induction therapy in solid organ transplantation.

Gharekhani A, Entezari-Maleki T, Dashti-Khavidaki S, Khalili H.

Expert Opin Biol Ther. 2013 Sep;13(9):1299-313. doi: 10.1517/14712598.2013.822064. Epub 2013 Jul 23. Review.

PMID:
23875884
7.

In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model.

Chappell D, Beiras-Fernandez A, Hammer C, Thein E.

Transplantation. 2006 Feb 27;81(4):552-8.

PMID:
16495803
8.

In vitro influence of polyclonal anti-thymocyte globulins on leukocyte expression of adhesion molecules.

Beiras-Fernandez A, Walther S, Kaczmarek I, Ngo T, Muenzinge S, Hammer C, Thein E.

Exp Clin Transplant. 2005 Dec;3(2):370-4.

9.

Induction of immunosuppression with polyclonal antithymocyte globulins: an overview.

Beiras-Fernandez A, Thein E, Hammer C.

Exp Clin Transplant. 2003 Dec;1(2):79-84. Review.

10.
11.

Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.

Libório AB, Mendoza TR, Esmeraldo RM, Oliveira ML, Paes FJ, Silva Junior GB, Daher EF.

Int Immunopharmacol. 2011 Nov;11(11):1832-6. doi: 10.1016/j.intimp.2011.07.012. Epub 2011 Aug 9.

PMID:
21835269
12.

Interaction of antithymocyte globulins with dendritic cell antigens.

Leitner J, Grabmeier-Pfistershammer K, Majdic O, Zlabinger G, Steinberger P.

Am J Transplant. 2011 Jan;11(1):138-45. doi: 10.1111/j.1600-6143.2010.03322.x. Epub 2010 Nov 18.

13.

Influence of polyclonal ATGs on expression of adhesion molecules: an experimental study.

Beiras-Fernandez A, Walther S, Thein E, Muenzing S, Hammer C.

Transplant Proc. 2005 May;37(4):1944-6.

PMID:
15919513
14.

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model.

Préville X, Flacher M, LeMauff B, Beauchard S, Davelu P, Tiollier J, Revillard JP.

Transplantation. 2001 Feb 15;71(3):460-8.

PMID:
11233911
15.

Influence of polyclonal antithymocyte globulins on the expression of adhesion molecules of isolated human umbilical vein endothelial cells.

Walther S, Beiras-Fernandez A, Csapo C, Münzing S, Stief CG, Hammer C, Reichart B, Thein E.

Transplant Proc. 2010 Jun;42(5):1931-4. doi: 10.1016/j.transproceed.2009.11.038.

PMID:
20620550
16.

The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.

Zahorsky-Reeves JL, Kearns-Jonker MK, Lam TT, Jackson JR, Morris RE, Starnes VA, Cramer DV.

Xenotransplantation. 2007 Mar;14(2):135-44.

PMID:
17381688
17.

Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion.

LaCorcia G, Swistak M, Lawendowski C, Duan S, Weeden T, Nahill S, Williams JM, Dzuris JL.

Transplantation. 2009 Apr 15;87(7):966-74. doi: 10.1097/TP.0b013e31819c84b8.

PMID:
19352114
18.

Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).

Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU.

J Heart Lung Transplant. 2005 Jun;24(6):708-13.

PMID:
15949731
19.

Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group.

Regan JF, Campbell K, Van Smith L, Schroeder TJ, Womble D, Kano J, Buelow R.

Transpl Immunol. 1999 Jun;7(2):115-21.

PMID:
10544442
20.

Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.

Bonaros N, Dunkler D, Kocher A, Imhof M, Grimm M, Zuckermann A, Wolner E, Laufer G.

J Heart Lung Transplant. 2006 Sep;25(9):1154-63. Epub 2006 Aug 8.

PMID:
16962480

Supplemental Content

Support Center